Consultant HaematologistChurchill Cancer Center, Oxford University Hospitals NHS Foundation TrustOxford, United Kingdom
N/A
(1548587) Genomic Evolution and Resistance to Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Chronic Lymphocytic Leukemia Patients: Results from the Phase I/II BRUIN Study
Sunday, October 8, 202312:35 PM – 12:40 PM EDT
(1552406) Sequencing of circulating tumour DNA reveals additional driver mutations in Richter Transformation
Monday, October 9, 20239:05 AM – 9:10 AM EDT